The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results from the LEADER trial.

by Ketan Dhatariya | Sep 3, 2018 | 2018, Original Articles

Dhatariya K, Bain SC, Buse JB, Simpson R, Tarnow L, Kaltoft MS, Stellfeld M, Tornøe K, Pratley RE, the LEADER Publication Committee on behalf of the LEADER Trial Investigators.

Diabetes Care 2018;41(10):2229-2235

Viewing the Paper

Please Note:

To view the paper please click on the image. It will then open directly in your browser. Alternatively, you can right click on the image and select 'Save linked file as' to download the PDF.
To download the latest Adobe PDF viewer please click here.

PROFESSOR KETAN DHATARIYA

Consultant in Diabetes, Endocrinology & General Medicine

The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results from the LEADER trial.

Recent Posts

Viewing the Paper

You have Successfully Subscribed!